Optiscan Imaging Ltd
ASX:OIL
Intrinsic Value
Optiscan Imaging Ltd. is engaged in the development of endomicroscopic imaging technologies for medical, translational and pre-clinical applications. [ Read More ]
The intrinsic value of one
OIL
stock under the Base Case scenario is
0.009
AUD.
Compared to the current market price of 0.085 AUD,
Optiscan Imaging Ltd
is
Overvalued by 89%.
OIL's market price has consistently been higher than its intrinsic value.This persistent overvaluation suggests the market may be overly optimistic about
OIL or that its price is influenced by factors unrelated to fundamentals.
Optiscan Imaging Ltd's market capitalization is 71m AUD.
OIL stock price is 0.085 AUD.
OIL stock (0.009 AUD) is 89% less than its price (0.085 AUD).
OIL. Open DCF Valuation
OIL stock (0.009 AUD) is 89% less than its price (0.085 AUD). Open Relative Valuation
OIL.
OIL's Revenue has been growing by 6% per year for the last 3 years.
OIL's Revenue has grown by an exceptional 85% over the past 12 months.
OIL's ROE (Return on Equity) has significantly decreased in the last 3 years from -21% to -51%, and is approaching profitability.
OIL's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from -56% to -98%, and is approaching profitability.
OIL has negative Operating Income for the last twelve months.
OIL has negative Net Income for the last twelve months.
OIL's ROE (Return on Equity) for the past 12 months is negative and is equal to -51%.
OIL's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -98%.
OIL has positive Gross Profit for the last twelve months.
OIL has negative Free Cash Flow for the last twelve months.
OIL's D/E (Debt to Equity) is very low and is equal to 0.02.
OIL has negative three-year average ROE (Return on Equity): -50%. The company is not efficient at transforming stockholders' equity into net income.
OIL has negative three-year average ROIC (Return on Invested Capital): -124%. The company is not efficient at using invested capital to generate operating income.
OIL's short-term assets (17m AUD) exceed its short-term liabilties (2m AUD).
OIL's long-term assets (18m AUD) exceed its long-term liabilties (2m AUD).
OIL has negative Net Debt. This means that the company has more cash and short-term investments (9m AUD) than debt (254k AUD).
OIL's Altman Z-Score is very high and is equal to 18.43.
Valuation Backtest
Optiscan Imaging Ltd
Run backtest to discover the historical profit from buying and selling
OIL
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Optiscan Imaging Ltd
Balance Sheet Decomposition
Optiscan Imaging Ltd
| Current Assets | 17.3m |
| Cash & Short-Term Investments | 8.7m |
| Receivables | 1.3m |
| Other Current Assets | 7.4m |
| Non-Current Assets | 789.8k |
| PP&E | 481.9k |
| Intangibles | 307.8k |
| Current Liabilities | 1.6m |
| Accounts Payable | 758.4k |
| Short-Term Debt | 175.5k |
| Other Current Liabilities | 700.6k |
| Non-Current Liabilities | 85.5k |
| Long-Term Debt | 78.4k |
| Other Non-Current Liabilities | 7.2k |
Earnings Waterfall
Optiscan Imaging Ltd
|
Revenue
|
1.7m
AUD
|
|
Cost of Revenue
|
815.7k
AUD
|
|
Gross Profit
|
2.5m
AUD
|
|
Operating Expenses
|
-8.2m
AUD
|
|
Operating Income
|
-5.7m
AUD
|
|
Other Expenses
|
270k
AUD
|
|
Net Income
|
-5.4m
AUD
|
Free Cash Flow Analysis
Optiscan Imaging Ltd
OIL Profitability Score
Profitability Due Diligence
Optiscan Imaging Ltd's profitability score is 14/100. The higher the profitability score, the more profitable the company is.
Score
Optiscan Imaging Ltd's profitability score is 14/100. The higher the profitability score, the more profitable the company is.
OIL Solvency Score
Solvency Due Diligence
Optiscan Imaging Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
Optiscan Imaging Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OIL Price Targets Summary
Optiscan Imaging Ltd
Shareholder Return
OIL Price
Optiscan Imaging Ltd
| Average Annual Return | 54.38% |
| Standard Deviation of Annual Returns | 106.18% |
| Max Drawdown | -84% |
| Market Capitalization | 71m AUD |
| Shares Outstanding | 835 340 992 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Optiscan Imaging Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Optiscan Imaging Ltd. is engaged in the development of endomicroscopic imaging technologies for medical, translational and pre-clinical applications. The company is headquartered in Mulgrave, Victoria. The firm has developed and commercialized confocal microscopes for clinical and pre-clinical applications. Its endomicroscopic technology enables 3D, in-vivo imaging of human tissue at the cellular level for cancer screening, diagnoses and in surgery. Its InVivage device is developed for clinical use in the oral cancer and other cancer applications. Its Fluorescence In Vivo Endomicroscopy (FIVE2) also known as ViewnVivo system, is a miniaturised confocal endomicroscope used for cellular level in-vivo imaging in living tissues. The firm also provides customization options for its product, (FIVE2).
Contact
IPO
Employees
Officers
The intrinsic value of one
OIL
stock under the Base Case scenario is
0.009
AUD.
Compared to the current market price of 0.085 AUD,
Optiscan Imaging Ltd
is
Overvalued by 89%.
You don't have any saved screeners yet
